As a nation where 90% of all people living with HIV know their diagnosis and are being treated, Germany has made great strides to advance its HIV care goals.
Gilead partners with various organizations that support people living with breast cancer. One such organization, the Young Survival Coalition (YSC), recognizes the unique needs of people of childbearing age and works with patients under 40.
In the second installment of our “Inside the Innovation” series, Gilead’s Ken Kent and Monica Tijerina discuss our patient-focused approach to developing medicines and the importance of including diverse voices throughout the process.
Gilead HIV Policy Directors Dan Murphy and Pema McGuinness recently developed a series of policy papers that warn of the consequences if governments fail to take steps to prioritize and invest in HIV.
As the ninth of 13 children, Dr. Carmen J. Walters grew up in New Orleans, where her father built houses during the day and worked at the railroad at night, and her mother did a variety of jobs, such as cooking for local schools.
The SABCS brings the scientific community and advocates together to focus on the biggest needs in breastcancer, including how the disease uniquely affects Black women.
Meet Brent Allan, a long-time HIV advocate in Australia who advises Gilead Sciences regarding programs that would best serve the needs of people living with HIV.
Gilead Sciences ranked No. 6 overall, and No. 2 within the Health Care & Life Sciences industry, in Newsweek’s just-released list of Most Responsible American Companies.
Gilead’s Corporate Social Responsibility (CSR) Report provides an overview of the work the company is doing around the world to improve the lives of...